Related Experiment Video

Updated: Mar 18, 2026

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

19.3K

Anaesthetic Management of a Child with Limb-Girdle Muscular Dystrophy

Gamze Sarkılar1, Aydın Mermer2, Melike Yücekul1

  • 1Department of Anaesthesiology and Reanimation, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey.

Turkish Journal of Anaesthesiology and Reanimation
|July 2, 2016
PubMed

Insights

Limb-girdle muscular dystrophy (LGMD) presents diverse challenges, particularly concerning surgical and anesthetic risks. This case report details the anesthetic management of a pediatric patient with LGMD, highlighting critical considerations for safe surgical procedures.

Area of Science:

  • Neurology
  • Anesthesiology
  • Genetics

Background:

  • Limb-girdle muscular dystrophies (LGMDs) encompass a heterogeneous group of genetic neuromuscular disorders.
  • LGMDs are characterized by progressive muscle weakness and wasting, primarily affecting the shoulders and hips.
  • These conditions can significantly increase perioperative risks, including respiratory compromise and cardiac complications.

Observation:

  • This case report focuses on the anesthetic management of a pediatric patient diagnosed with limb-girdle muscular dystrophy.
  • The patient's specific subtype of LGMD and associated clinical features were carefully evaluated.
  • Pre-anesthetic assessment identified potential anesthetic challenges and risks.

Findings:

  • The anesthetic plan was tailored to the patient's specific condition, prioritizing airway management and cardiovascular stability.
  • Careful selection of anesthetic agents and techniques was crucial to minimize potential adverse effects.
  • Monitoring for intraoperative and postoperative complications was rigorous.

Implications:

  • This case underscores the importance of a multidisciplinary approach in managing patients with LGMD undergoing surgery.
  • Anesthesiologists must be aware of the unique perioperative risks associated with LGMD subtypes.
  • Optimized anesthetic strategies can improve surgical outcomes and patient safety in this vulnerable population.

Keywords:
Childgeneral anaesthesiamuscular dystrophies

More Related Videos

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies14:10

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies

Published on: January 31, 2013

34.1K
Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

8.1K

Related Concept Videos

Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.1K
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
1.0K
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
695
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
882
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
1.3K
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.3K